Kenneth Inchausti
Corporate Officer/Principal presso Novo Nordisk, Inc.
Profilo
Kenneth Inchausti is currently the Director-Corporate Branding & Reputation at Novo Nordisk, Inc. Previously, he worked as the Head-Investor Relations & Communications at Ocugen, Inc. Mr. Inchausti completed his undergraduate degree at Old Dominion University.
Posizioni attive di Kenneth Inchausti
| Società | Posizione | Inizio |
|---|---|---|
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | 25/09/2014 |
Precedenti posizioni note di Kenneth Inchausti
| Società | Posizione | Fine |
|---|---|---|
| OCUGEN, INC. | Investor Relations Contact | 01/06/2022 |
Formazione di Kenneth Inchausti
| Old Dominion University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OCUGEN, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
- Borsa valori
- Insiders
- Kenneth Inchausti
